Similarly, previous studies have demonstrated that STAT6 inhibition with AS1517499 suppresses the anti-inflammatory macrophage phenotype in vitro, whilst leading to reduced primary breast tumour volume and lower incidence of liver metastasis in vivo (6). Here, STAT6 is linked to breast neoplasm.